MeSH tree: C10.668
In Canada, between 3,000 and 4,000 people are living with amyotrophic lateral sclerosis (ALS), a disease that remains incurable. ALS is best known for the degeneration of motor neurons, which are responsible for controlling ...
Jun 2, 2026
0
9
Researchers at Cincinnati Children's have identified a potential new way to relieve chronic pain linked to neurofibromatosis type 1 (NF1), a genetic condition best known for causing tumors to grow along nerves. The new findings ...
May 27, 2026
0
3
At age 49, Jan Janisch-Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a desk role. Frequent falls made her afraid to carry her grandchildren. She ...
May 26, 2026
0
2147
Rugby league player Jai Arrow's recently announced diagnosis of motor neuron disease has again brought this devastating disease to public attention.
May 22, 2026
0
5
Researchers have developed a technique that can identify errors caused by mutations linked to a range of genetic disorders, including forms of muscular dystrophy, Huntington's disease and amyotrophic lateral sclerosis (ALS), ...
May 21, 2026
0
8
A lightweight robotic device that facilitates neuromuscular recovery in children with spinal muscular atrophy (SMA), helping them to stand unassisted, is published in Nature this week. Improved function persists after discontinuing ...
May 21, 2026
0
4
Competing in esports, also known as electronic sports, can mean training for several hours a day in front of a screen. Whether people participate in video game competitions at the professional or amateur level, they face ...
May 21, 2026
0
2
A research team at the Brain Research Institute, Niigata University has found that APOE ε4, a genetic factor best known for increasing the risk of Alzheimer's disease, may also influence how pathological changes spread in ...
May 20, 2026
0
3
The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with (gMG). The ...
May 18, 2026
0
7
Thousands of Americans develop chronic persistent symptoms—such as fatigue, cognitive difficulties ("brain fog"), and other debilitating issues—each year following acute infections from Lyme disease, COVID-19, and other pathogens. ...
May 14, 2026
0
13
